Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Peninsula spin-off Cerexa gets $50mm with financing
30 Aug 2005
Antibiotics company Cerexa brought in $50mm with its first financing round led by Frazier Healthcare Ventures and New Leaf Venture Partners. Also participating were existing backers AM Pappas & Associates, Canaan Partners, CDIB BioScience Ventures, Domain Associates, EGS Heathcare Capital, Montreux Equity Partners, and OrbiMed Advisors.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?